Mazdutide 5mg Peptides
Designed for exacting lab work, this research-grade peptide is prepared to meet the demands of disciplined, reproducible studies.
Mazdutide 5mg is presented as a lyophilized peptide vial (unflavored, laboratory style) featuring a single active peptide compound at a total content of 5mg per vial. The stabilized dry form supports controlled handling, consistent preparation, and reliable performance across method development and validation workflows.
- Each vial contains 5mg of Mazdutide, a dual-pathway peptide investigated for activity at glucagon-like peptide-1 and glucagon receptors, enabling studies focused on metabolic signaling, energy balance pathways, and related receptor pharmacology.
This non-edible research format offers a clean, uniform powder surface ideal for protocol-driven reconstitution and aliquoting under controlled conditions. Investigators value the straightforward presentation for assay setup, dose-ranging exploration, reference standard comparisons, and mechanistic inquiry where consistency and traceability matter.
Ingredients: Mazdutide (lyophilized peptide powder).
Each lot is prepared to rigorous internal specifications, with identity and purity verified by appropriate analytical methods such as HPLC and LC-MS. Vials are lot-coded for traceability and packaged to support integrity from receipt through study execution. Documentation is available to support quality review, and handling guidance is aligned with common laboratory standards so teams can integrate the material into existing SOPs with confidence.
Research Use Only: This peptide is intended strictly for laboratory research. It is not a drug, food, or cosmetic, and is not for human or animal consumption, therapeutic use, or diagnostic procedures. Use by qualified personnel only, in appropriate facilities and in accordance with applicable regulations and safety practices.
Peptide Scientific Labs maintains a USA-based supply chain with a disciplined approach to sourcing, manufacturing, and quality control. From careful material selection to lot-level testing and final release, our process prioritizes purity, consistency, and transparency. Each vial reflects a commitment to dependable laboratory performance so researchers can focus on the work—supported by clear specifications, trustworthy analysis, and the standards-first mindset that defines our brand.
- Most orders ship within 24 hours and arrive within 3 to 5 days of leaving our warehouse.
- Shipping is free on orders of $99+ (except Hawaii and Alaska).
- All orders ship in discreet packaging via USPS Ground Advantage mail.
Delivery restrictions vary by state.
This Product Contains
Customer Reviews
There are no reviews yet. Be the first to write a review!
Frequently Asked Questions
What are GLP peptides?
GLP peptides — glucagon-like peptides — are a family of peptides derived from the post-translational processing of the proglucagon precursor. The main members are GLP-1 and GLP-2, both of which are produced primarily by intestinal L-cells. GLP-1 is studied in the context of insulin secretion, glucose metabolism, and appetite signaling, while GLP-2 is investigated for its role in intestinal epithelial biology.
A number of synthetic analogs and research compounds exist in this category, including semaglutide-class and tirzepatide-class sequences, as well as dual- and triple-agonist research peptides. All GLP peptide products from Peptide Scientific Labs are lyophilized research materials intended solely for in vitro laboratory investigation.
How do GLP analogs differ from native GLP hormones?
Native GLP-1 has a very short half-life in plasma — on the order of a few minutes — because it is rapidly degraded by the enzyme dipeptidyl peptidase-4 (DPP-4). GLP analogs are engineered peptides that modify the native sequence or attach additional groups such as fatty acid chains, in order to resist DPP-4 degradation, extend half-life, and optimize receptor binding.
This extended stability is what makes GLP analogs useful in research as practical tools for studying the GLP-1 and related receptor systems in controlled experiments. The analogs differ from native GLP hormones primarily in their pharmacokinetic profile and, in some cases, their receptor selectivity across the GLP-1, GIP, and glucagon receptor families.
What is the difference between GLP-1, GLP-2, and GLP-3 in research?
GLP-1 and GLP-2 are both produced from the proglucagon precursor. GLP-1 is studied in connection with the GLP-1 receptor, insulin secretion, and appetite signaling, while GLP-2 is studied primarily in connection with the GLP-2 receptor and intestinal epithelial biology. The two peptides share a common precursor but have different receptor targets and research focuses.
GLP-3 is not a classical endogenous peptide in the same way as GLP-1 and GLP-2. The term is sometimes used as a research label for engineered or triple-agonist peptides that combine activity at GLP-1, GIP, and glucagon receptors in a single molecule. In this sense, GLP-3 in research usually refers to a designed multi-target compound rather than a naturally occurring hormone.
